Skip to main content
. 2020 Jun 23;4(9):bvaa076. doi: 10.1210/jendso/bvaa076

Table 4.

Participant-reported outcomesa

Baseline
(N = 34)
Month 1 (N = 34) Month 2b
(N = 33)
Month 3 (N = 34) P for change from baseline to month 3d
CGM Self Efficacy Scale Mean Score NA 5.3 (4.7, 5.8) NA 5.5 (5.3, 6.0) NA
Median (quartiles) (range, 0-6)
Diabetes Distress Scale Management 1.8 (0.8, 2.5) 0.6 (0.3, 1.3) 0.5 (0.3, 1.0) 0.5 (0.3, 1.3) < .001
Distress Subscale Mean Score
Median (quartiles) (range, 0-5)
Glucose Monitoring Satisfaction Survey 3.2 ± 0.6 3.7 ± 0.8 3.9 ± 0.6 3.9 ± 0.7 < .001
Mean score
Mean ± SD (range, 1-5)
Openness Subscale Mean score 2.6 ± 0.7 3.4 ± 0.9 3.6 ± 0.6 3.7 ± 0.9 < .001
Mean ± SD (range, 1-5)
Emotional Burden Subscale Mean Score 2.6 ± 0.8 2.3 ± 0.9 2.1 ± 0.8 2.2 ± 0.8 .003
Mean ± SD (range, 1-5)
Behavioral Burden Subscale Mean Score 2.9 (2.0, 3.3) 1.5 (1.0, 2.8) 1.8 (1.3, 2.0) 1.9 (1.0, 2.5) < .001
Median (quartiles) (range, 1-5)
Trust Subscale Mean Score 3.7 (3.0, 4.0) 4.0 (3.0, 4.3) 4.0 (3.0, 4.7) 4.0 (3.3, 5.0) .02
Median (quartiles) (range, 1-5)
Hypoglycemia Confidence Survey Mean 2.1 (1.4, 2.6) 2.4 (2.2, 2.8) NA 2.3 (2.0, 2.9) c < .001
Score
Median (quartiles) (range, 0-3)
Diabetes Technology Attitudes Survey 4.0 (3.6, 4.4) 4.4 (4.0, 5.0) NA 4.8 (4.0, 5.0) < .001
Mean score
Median (quartiles) (range, 1-5)
Benefits and Barriers of CGM Survey 2.2 (1.8, 2.7) 1.7 (1.4, 2.0) NA 1.5 (1.2, 2.2) < .001
Mean score
Median (quartiles) (range, 1-5)

Abbreviations: CGM, continuous glucose monitoring; HbA1c, hemoglobin A1c; NA, not available.

aShaded rows denote questionnaires for which a higher score is better.

bOne participant did not complete questionnaires at month 2.

cOne participant who completed the questionnaires at month 3 did not complete the Hypoglycemia Confidence Survey.

dBased on a Wilcoxon signed rank test. For the Clarke Hypoglycemia Unawareness Survey; the Fisher exact test was used instead.